Top compounds associated with response to C20orf96


Feature Type Standardized
Nominal ANOVA
mRNA CAY10603 GDSC1000 pan-cancer AAC 0.13 2e-05
mRNA BRD-K41597374 CTRPv2 pan-cancer AAC 0.16 2e-05
mRNA XMD13-2 GDSC1000 pan-cancer AAC 0.14 2e-05
mRNA BRD-A02303741:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.16 2e-05
mRNA MLN4924 CTRPv2 pan-cancer AAC 0.15 2e-05
mRNA paclitaxel CTRPv2 pan-cancer AAC 0.14 2e-05
mRNA RG-108 CTRPv2 pan-cancer AAC 0.16 2e-05
mRNA oligomycin a CTRPv2 pan-cancer AAC 0.16 2e-05
mRNA Methotrexate GDSC1000 pan-cancer AAC 0.13 3e-05
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.15 3e-05
Download CSV